Apigenin improves cytotoxicity of antiretroviral drugs against htlv-1 infected cells through the modulation of ahr signaling

HIGHLIGHTS

• who: NeuroImmune Pharmacol. Ther. and collaborators from the Immunology, Drexel University College of Medicine, Queen Lane, Drexel University College of Medicine, Philadelphia, PA, USA have published the research work: Apigenin improves cytotoxicity of antiretroviral drugs against HTLV-1 infected cells through the modulation of AhR signaling, in the Journal: (JOURNAL)
• what: The authors provided confirmation of interaction of Apigenin with AhR as a direct ligand. The studies demonstrate that within PBMCs, a similar pattern of AhR activation can be observed by stimulation of the AhR by Apigenin and its derivative compound, VY-3-68, although . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.